You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 13, 2025

List of Excipients in API elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide

Glossary

Detailed excipient profiles for elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide

Excipient focus: CELLULOSE, MICROCRYSTALLINE

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing CELLULOSE, MICROCRYSTALLINE

Glossary

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing CELLULOSE, MICROCRYSTALLINE

Glossary
CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: CROSCARMELLOSE SODIUM

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing CROSCARMELLOSE SODIUM

Glossary

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing CROSCARMELLOSE SODIUM

Glossary
CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: FD&C BLUE NO. 2

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing FD&C BLUE NO. 2

Glossary

Excipient focus: FERRIC OXIDE YELLOW

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing FERRIC OXIDE YELLOW

Glossary

Excipient focus: HYDROXYPROPYL CELLULOSE

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing HYDROXYPROPYL CELLULOSE

Glossary

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing HYDROXYPROPYL CELLULOSE

Glossary
CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: LACTOSE MONOHYDRATE

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing LACTOSE MONOHYDRATE

Glossary

Excipient focus: MAGNESIUM STEARATE

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing MAGNESIUM STEARATE

Glossary

Excipient focus: POLYETHYLENE GLYCOL

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing POLYETHYLENE GLYCOL

Glossary

Excipient focus: POLYVINYL ALCOHOL

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing POLYVINYL ALCOHOL

Glossary

Excipient focus: SODIUM LAURYL SULFATE

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing SODIUM LAURYL SULFATE

Glossary

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants not containing SODIUM LAURYL SULFATE

Glossary
CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide drug variants containing TITANIUM DIOXIDE

Glossary

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group